Affiliation:
1. Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Surgical Research Laboratory, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Abstract
AbstractPatients with liver disease acquire complex changes in their hemostatic system. Historically, these patients were considered to have a bleeding tendency related, in part, to a hyperfibrinolytic state. However, studies using more modern fibrinolysis tests have questioned the presence of a hyperfibrinolytic state in patients with liver disease and its association with bleeding risk. It may be that the sickest patients with liver disease do have fibrinolytic abnormalities. However, the debate on the fibrinolytic state of patients with (decompensated) cirrhosis or critically ill liver disease is complicated by the fact that hypo- and hyperfibrinolysis have been poorly defined. This could, in part, be explained by the lack of reliable tests that assess a patient's fibrinolytic status. Moreover, large clinical studies on the relationship between bleeding and fibrinolysis in patients with liver disease are scarce. Here, we provide an overview of the current knowledge on fibrinolysis in various types of liver diseases and possible implications as a target for therapeutic strategies in liver disease. As antifibrinolytic therapy has been shown to be safe and effective during liver transplantation, it could potentially be of use in patients with (either laboratory-established or suspected) hyperfibrinolysis-related bleeding.
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference80 articles.
1. Haemostatic abnormalities in patients with liver disease;T Lisman;J Hepatol,2002
2. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases;T Lisman;Res Pract Thromb Haemost,2017
3. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia;D Ferro;Hepatology,1996
4. Sepsis, thrombosis and organ dysfunction;N Semeraro;Thromb Res,2012
5. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways;S J van Deventer;Blood,1990
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献